Effects of Adiposity on Plasma Lipid Response to Reductions in Dietary Saturated Fatty Acids and Cholesterol
Authors:
- Michael H. GreenMGMichael H. Green
- Penny M. Kris-EthertonPKPenny M. Kris-Etherton
- 1 May 2011
- journal article
- review article
- Published by Elsevier in Advances in Nutrition
- Vol. 2 (3) , 261-274
Abstract
Dietary SFA and cholesterol are major targets for reducing plasma total and LDL cholesterol as a strategy to decrease cardiovascular disease risk. However, many studies show that excess adiposity attenuates the expected lipid and lipoprotein response to a plasma cholesterol-lowering diet. Diets low in SFA and cholesterol are less effective in improving the lipid profile in obese individuals and in patients with metabolic syndrome. In contrast, lean persons are more responsive to reductions in dietary SFA and cholesterol. Multiple mechanisms likely contribute to the altered plasma lipid responses to dietary changes in individuals with excess adiposity. The greater rate of hepatic cholesterol synthesis in obese individuals suppresses the expression of hepatic LDL receptors (LDLR), thereby reducing hepatic LDL uptake. Insulin resistance develops as a result of adipose-tissue induced inflammation, causing significant changes in enzymes necessary for normal lipid metabolism. In addition, the LDLR-mediated uptake in obesity is attenuated by alterations in neuroendocrine regulation of hormonal secretions (e.g. growth hormone, thyroid hormone, and cortisol) as well as the unique gut microbiota, the latter of which appears to affect lipid absorption. Reducing adipose tissue mass, especially from the abdominal region, is an effective strategy to improve the lipid response to dietary interventions by reducing inflammation, enhancing insulin sensitivity, and improving LDLR binding. Thus, normalizing adipose tissue mass is an important goal for maximizing the diet response to a plasma cholesterol-lowering diet.Keywords
This publication has 125 references indexed in Scilit:
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistanceNature Medicine, 2011
- Nut Consumption and Blood Lipid LevelsArchives of internal medicine (1960), 2010
- Adipose Inflammation, Insulin Resistance, and Cardiovascular DiseaseJournal of Parenteral and Enteral Nutrition, 2008
- Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated andNpc1l1−/−miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Insulin sensitivity: modulation by nutrients and inflammationJournal of Clinical Investigation, 2008
- TGFβ1, TNFα, and insulin signaling crosstalk in regulation of the rat cholesterol 7α-hydroxylase gene expressionJournal of Lipid Research, 2008
- Inflammation and insulin resistanceFEBS Letters, 2007
- Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytesPflügers Archiv - European Journal of Physiology, 2007
- TLR4 links innate immunity and fatty acid–induced insulin resistanceJournal of Clinical Investigation, 2006
- Bile acids and cytokines inhibit the human cholesterol 7α‐hydroxylase gene via the JNK/c‐jun pathway in human liver cells†Hepatology, 2006